GOOD…BAD…AND IN BETWEEN: NEW LITERATURE HIGHLIGHTS Top Article of 2019 Carbone M, Adusumilli PS, Alexander Jr HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley ‐ Bosco E, Galateau ‐ Sa lle F, Jablons D, Mansfield AS, “M esothelioma: Scientific clues for pre vention, diagnosis, and therapy,” CA: A Cancer Journal For Clinicians , 2019 Sep 1;(69(5):402-429 Non-Asbestos Related Meso Attanoos RL, Churg A, Galateau- Salle F, Gibbs AR, Roggli VL, “M alignant mesothelioma and its non-asbestos cau ses,” Archives of Pathology & Laboratory Medicine , 2018 Feb 26;142(6):753-60. *Finkelstein MM. “ Malignant Mesothel ioma and Its Nonasbestos Causes,” Archives of Pathology & Laboratory Medicine , 2019 Jun;143(6):659. Attanoos RL, Churg A, Galateau- Salle F, Gibbs AR, Roggli VL. In Reply to “Malignant Mesotheli oma and Its Nonasbestos Causes”, Archives of Pathology & Laboratory Medicine . 2019 Aug;143(8):911-4. Fiber Potency Korchevskiy A, Rasmuson JO, Rasmuson EJ. Empirical model of mesothelioma potency factors for different mineral fibers based on their chemical composition and dimensionality. Inhalation Toxicology . 2019 Apr 16;31(5):180-91 Localized Mesothelioma Marchevsky AM, Khoor A, Walts AE, Nicholson AG, Zhang YZ, Roggli V, Carney J, Roden AC, Ta zelaar HD, Larsen BT, LeStang N, “ Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the I nternational Mesothelioma Panel,” Modern Pathology ,” 2019 Sep 4:1-6. Hung YP, Dong F, Dubuc AM, Dal Cin P, Bueno R, Chirieac LR, “ Molecular characterization of localized pleural mesothelioma,” Modern Pathology . 2019 Aug 1:1-0 I-1635547.1 Willcox Savage
New Literature Highlights – 2019 Reading List Genetic Predisposition to Cancer/Mesothelioma - Hassan R, Morrow B, Thomas A, Walsh T, Lee MK, Gulsuner S, Gadiraju M, Panou V, Gao S, Mian I, Khan J, “ Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy,” Proceedings of the National Academy of Sciences. 2019 Apr 30;116(18):9008-13 (Commentary) - Martincorena I, “ Somatic mutation and clonal expansions in human tissues, Genome Medicine , 2019 Dec;11(1):35 (Commentary) - Zauderer MG, Jayakumaran G, DuBoff M, Zhang L, Francis JH, Abramson DH, Cercek A, Nash GM, Shoushtari A, Chapman P, D’Angelo S., “ Prevalence and Preliminary Validation of Screening Criteria to Identify Carr iers of Germline BAP1 Mutations,” Journal of Thoracic Oncology , 2019 Jul 16; 14(11):189-1994 - Yizhak K, Aguet F, Kim J, Hess JM, Kübler K, Grimsby J, Frazer R, Zhang H, Harad hvala NJ, Rosebrock D, Livitz D, “ RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues,” Science , 2019 Jun 7;364(6444):eaaw0726 - Carbone M, Adusumilli PS, Alexander Jr HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley ‐ Bosco E, Galateau ‐ S alle F, Jablons D, Mansfield AS, “ Mesothelioma: Scientific clues for prevention, diagnosis, and therapy ,” CA: A Cancer Journal For Clinicians , 2019 Sep 1;(69(5):402-429 - Tomasetti C., “M ut ated clones are the new normal”, Science . 2019 Jun 7;364(6444):938- 9 - K ennedy SR, Zhang Y, Risques RA., “ Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detecti on,” Trends in Cancer . 2019 Sep;5(9):531-540 - Levpuscek, “The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma,” Radiol Oncol 2019; 53(2): 206-212 - Coco S, Bonfiglio S, Cittaro D, Vanni I, Mora M, Genova C, Dal Bello MG, Boccardo S, Alama A, Rijavec E, Sini C, “ Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. Cancers, 2019 Apr;11(4):441. - Betti M, Aspesi A, Sculco M, Ma tullo G, Magnani C, Dianzani I., “ Genetic predisposition for malignant mesothelioma: a concise review,” Mutation Research/Reviews in Mutation Research , 2019 Mar 6 2 I-1635547.1 Willcox Savage
Nanotubes/Asbestos/Inflammation Dong J, Ma Q. “ Integration of inflammation, fibrosis, and can cer induced by carbon nanotubes,” Nanotoxicology . 2019 Oct 21;13(9):1244-74 Emerce E, Ghosh M, Ỏ ner D, Duca RC, Vanoirbeek J, Bekaert B, Hoet PH, Godderis L., “ Carbon Nanotube-and Asbestos-Induced DNA and RNA Methylation Changes in Bronchial Epithelial Cells,” Chemical Research in Toxicology , 2019 May 1 Talc Marsh GM, Ierardi AM, Benson SM, Finley BL. “ Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration of latency period,” Inhalation Toxicology . 2019 May 12;31(6):213-23 Fordyce TA, Leonha rd M, Mowat FS, Moolgavkar SH, “ A 37-year Update on Mortality Patterns in an Expanded Cohort of Vermont Talc Miners and Millers,” Journal of Occupational And Environmental Medicine . 2019 Nov;61(11):916-923 Taher MK, Farhat N, Karyakina NA, Shilnikova N, Ramoju S, Gravel CA, Krishnan K, Mattison D, Wen SW, Krewski D., “C ritical Review of the Association between Perineal Use of Talc Po wder and Risk of Ovarian Cancer,” Reproductive Toxicology , 2019 Aug 28;90:88-101 McDonald SA, Fan Y, We lch WR, Cramer DW, Godleski JJ, “ Migration of Talc From the Perineum to Multiple Pelvic Organ Sites: Five Case Studies With Correlative Light and Scanning Electron Microscopy,” American Journal of Clinical Pathology , 2019 Jul 15;152(5):590-607 O’Brien KM, D’Aloisio AA, Shi M, Murphy JD, Sandler DP, Weinberg CR, “ Perineal Talc Use, Douching, and the Risk of Uterine Cancer,” Epidemiology , 2019 Nov 1;30(6):845-52 Rasmussen PE, Levevsque C, Niu, J, Gardner ., “Characterization of airborne Particle s Emitted During application of Cosmetic Talc Products,” Int J Environ Res Public Health , 2019, 16, 3830 Tran TH, Steffen JE, Clancy KM, B ird T, Egilman DS, “ Talc, Asbestos, and Epidemiology: Corporate Influe nce and Scientific Incognizance,” Epidemiology . 2019 Nov 1;30(6):783-8 Gabriel IM, Vitonis AF , Welch WR, Titus L, Cramer DW., “ Douching, talc use, and risk for ovarian cancer and conditions relate d to genital tract inflammation,” Cancer Epidemiology and Prevention Biomarkers . 2019 Nov 1;28(11):1835-44 Rosner, et al., “Nondetected: The Politics of Measurement of Asbestos in Talc, 1971–1976,” AJPH July 2019, Vol 109, No. Rosner D, Markowitz G, Chowkwanyun M. “Nondetected”: The Politics of Measurement of Asbestos in Talc, 1971 –1976,” American Journal of Public Health . 2019 Jul;109(7):969-77 3 I-1635547.1 Willcox Savage
Idiopathic Interstitial Fibrosis & Lung Cancer Whittaker Brown SA, Dobelle M, Padilla M, Agovino M, Wisnivesky JP, Hashim D, Boffetta P. “ Idiopathic Pulmonary Fibrosis and Lung Cancer: A Systematic Review and Meta- Analysis,” Annals of the American Thoracic Society , 2019 Aug;16(8):1041-1051 Ballester B, Milara J, Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets. International Journal of Molecular Sciences . 2019 Jan;20(3):593 Friction Products Poland CA, Duffin R, “ The toxicology of chrysotile-containing brake debris: implications for mesothelioma,” Critical Reviews in Toxicology , 2019 Jan 2;49(1):11-35. Risk of Meso after Cessation of Exposure Boffetta P, Donato F, Pira E, Luu HN, La Vecchia C, “ Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta- regression,” International Archives of Occupational and Environmental Health , 2019 Oct;92(7):949-957 Fiber Burden Roggli VL, Green CL. , “ Dimensions of elongated mineral particles: a study of more than 570 fibers from more than 90 cases with implications for pathogenicity and classification as asb estiform vs. cleavage fragments,” Ultrastructural Pathology , 2019 Jan 2;43(1):1-5 WDPM Kim M, Kim HS, “ Clinicopathological Characteristics of Well-differentiated Papillary Mesothelioma of The Peritoneum: A Single-institutional Experience of 12 Cases. In Vivo , 2019 Mar 1;33(2):633-42 Sun, Hongbing, “North -south gradient of mesothelioma and asbestos consumption-production in the United States- Progresses since the 1st asbestos partial ban in 1973,” Am J Ind Med , 2019;62:337-346 Vogin G, Hettal L, Vignaud JM, Dartigues P, Goere D, Ferron G, Heyd B, Bereder JM, Tuech JJ, Glehen O, de Chaisemart in, “ Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from th e RENAPE Observational Registry,” Annals of Surgical Oncology , 2019 Mar 15;26(3):852-60 4 I-1635547.1 Willcox Savage
Recommend
More recommend
